Almac Group
20 Seagoe Industrial Estate
Craigavon
BT63 5QD
United Kingdom
Tel: 44-28-3833-2200
Fax: 44-28-3833-2299
Website: http://www.almacgroup.com/
Email: info@almacgroup.com
205 articles about Almac Group
-
InMed and Almac Group Developing Improved Cannabinoid Production Methods
5/5/2020
InMed Pharmaceuticals Inc., a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way in the clinical development of cannabinol, announced that it is working with the Almac Group on a proprietary approach to augment current biosynthesis-based methods for cannabinoid production.
-
Almac Group launches enhanced Label Approval Solution (LAS)
2/6/2020
Delivering an efficient, seamless process for clinical labels from protocol to print
-
Almac Group and Exostar Collaborate to offer Better IRT Experience
12/12/2019
Almac Clinical Technologies has announced the launch of a standardized, operationally-proven integration between its Interactive Response Technology platform - IXRS® 3 and Exostar’s Identity and Access Management Platform.
-
Bill & Melinda Gates Foundation awards Almac Group $200,000 funding for developing world aid programs
12/4/2019
Almac scientists to develop novel manufacturing process for essential medicine
-
Almac Group Participates in Global Clinical Supply BlockChain Working Group
9/17/2019
Almac Group, the global contract pharmaceutical development and manufacturing organization, is pleased to announce its participation in the Global Clinical Supply BlockChain working group.
-
Almac Group to Host EU Launch Workshop Series in California and Washington States
8/1/2019
Almac Pharma Services, part of the global contract pharmaceutical development and manufacturing organisation, the Almac Group, is inviting members of the pharmaceutical and biotechnology industry to join its upcoming complimentary workshop series this September.
-
Almac Group Invites Biopharma Industry Members to Learn About Almac Adapt™ - Just in Time Manufacturing at Complimentary Workshop
8/1/2019
Almac Clinical Services, part of the global contract pharmaceutical development and manufacturing organization the Almac Group, is delighted to invite participants from the Biopharma industry to join its Souderton Lunch and Learn Workshop on Wednesday, September 18.
-
Almac Group Recognised with Six Life Science Leader CMO Awards
3/26/2019
These awards recognise Almac’s global reputation for excellence built over 50 years of client service across the drug development and commercialisation lifecycle and is the organisation’s seventh consecutive year of winning the awards.
-
Almac Group Announces Almac One™ – A Unified Clinical Trial Supply Solution
3/6/2019
Unique solution offers sponsors a streamlined approach to the global supply chain
-
Almac Group extends personalised cancer vaccine production facilities
1/17/2019
The Almac Group, a CDMO serving the pharmaceutical and biotech sectors globally, is expanding its Edinburgh Technopole facility to allow scale-up of its personalised cancer vaccine activities.
-
Almac Group Invites Attendees to Join Workshop in San Diego to Learn About Cold Chain Management in Clinical Trials
12/14/2018
Almac Clinical Services, part of the global contract pharmaceutical development and manufacturing organisation the Almac Group, is pleased to invite participants from the pharmaceutical and biopharma industries to join its San Diego lunch and learn to discuss cold chain management in clinical trials.
-
Almac Group Announces Successful HSA Inspection of Singapore Facility
10/22/2018
Growth in Asia continues with ongoing investment in Headquarters site
-
Almac Group Invests to Expand its Existing North Carolina Facility
10/10/2018
Continued expansion and investment to support increasing client demand
-
Almac Group Announces Successful HPRA Inspection at its European Campus
10/2/2018
Almac Group is pleased to announce the successful inspection of Almac Pharma Services (Ireland) at its European campus in Dundalk, Ireland, by the Health Products Regulatory Authority (HPRA).
-
Almac Group Launches Global Analytical Services Capability
10/1/2018
Almac Group is delighted to announce its global analytical services capabilities spanning UK, Europe and North America.
-
Almac Group to Host Clinical Trial Supply Lunch and Learn at North American Headquarters
9/10/2018
Almac Clinical Services, part of the global contract pharmaceutical development and manufacturing organization, the Almac Group, is delighted to invite participants from the Biopharma Industry to join its fourth consecutive North American and seventh global “lunch and learn” seminar this year, building on its unique global knowledge share series.
-
Almac Group Appoints New Site Head for Charnwood Campus, Loughborough, UK
8/27/2018
Almac Group, the global contract pharmaceutical development and manufacturing organisation, has announced the appointment of a new Site Head for its Charnwood campus, in Loughborough, UK.
-
Almac Group Appoints Jonothan Cooil as Vice President of Engineering, Facilities and Health, Safety & Environment
8/21/2018
Almac Group, the global contract pharmaceutical development and manufacturing organisation, has announced the appointment of Jonothan Cooil to Vice President of Engineering, Facilities and Health, Safety & Environment. He will report to Almac Group CEO, Alan Armstrong.
-
Almac Group Appoints Dr. Stefan Mix as Head of Biocatalysis
1/29/2018
In his new role, Stefan, who is the author of several publications will be responsible for the development and application of platform technologies within Almac Sciences leading a team of almost 50 scientists, in addition to supporting and directing commercialisation of new technology.
-
Almac Group Launches Bespoke Elemental Impurities Laboratory
1/24/2018
n response to these demands, Almac Group has announced significant investment in a state-of-the-art elemental impurities analysis laboratory at their European Headquarters, Craigavon, UK.